sulfaphenazole has been researched along with Cardiac Failure in 2 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heim, R | 1 |
| Lucas, S | 1 |
| Grombein, CM | 1 |
| Ries, C | 1 |
| Schewe, KE | 1 |
| Negri, M | 1 |
| Müller-Vieira, U | 1 |
| Birk, B | 1 |
| Hartmann, RW | 1 |
| Fischer, D | 1 |
| Landmesser, U | 1 |
| Spiekermann, S | 1 |
| Hilfiker-Kleiner, D | 1 |
| Hospely, M | 1 |
| Müller, M | 1 |
| Busse, R | 1 |
| Fleming, I | 1 |
| Drexler, H | 1 |
2 other studies available for sulfaphenazole and Cardiac Failure
| Article | Year |
|---|---|
Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity.
Topics: Animals; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Fibr | 2008 |
Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure.
Topics: Aged; Anti-Infective Agents; Arteries; Aryl Hydrocarbon Hydroxylases; Chronic Disease; Cytochrome P- | 2007 |